Applied Therapeutics Aktie (A2PHHB

Chart der Applied Therapeutics Aktie

Charttool öffnen

Aktuelle Nachrichten zu Applied Therapeutics

Weitere Nachrichten

Unsere neuesten Artikel zu Applied Therapeutics

Fast Track-Zulassung der FDA als Katalysator für Trendschub in Richtung 52 Wochenhoch

Applied Therapeutics Inc. (APLT) (i.) hat eine Fast Track-Zulassung auf AT-007 zur Behandlung von Galaktosämie, einer seltenen Stoffwechselerkrankung erhalten. AT-007 ist der in das Zentralnervensystem eindringende Aldose-Reduktase-Inhibitor des Unternehmens in der Entwicklung für mehrere seltene Stoffwechselerkrankungen, darunter Galaktosämie, SORD und PMM2-CDG. Diese Nachricht könnte ein wichtiger...

Das berichten andere über Applied Therapeutics

Applied Therapeutics (APLT) Upgraded to Buy: Heres Why

Applied Therapeutics (APLT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

APLT COURT NEWS: Applied Therapeutics has been Sued for Securities Fraud; Contact BFA Law by February 18 if You Lost Money (NASDAQ:APLT)

Applied Therapeutics, Inc. investors that lost money are encouraged to contact BFA Law before February 18, 2025 class action deadline.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Kaspi, Applied Therapeutics, Nextracker, and MGPI and Encourages Investors to Contact the Firm

NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been...

APLT DEADLINE NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Applied Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT

NEW YORK, Feb. 08, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ:...